OmniaBio Expands Manufacturing Footprint with Second Hamilton Location January 24, 2023 (Hamilton, ON) – OmniaBio Inc. has expanded its footprint by adding a new process and analytical development lab space at the McMaster University Medical Centre (MUMC). The new facility is now...
MicrofluidX and CCRM Partner on End-to-End Bioprocessing of CAR-T Cell Therapies Stevenage, UK, and Toronto, Canada, January 11, 2023— MicrofluidX (MFX), a UK-based provider of next-generation bioreactors for cell research and manufacturing, today announced a partnership with CCRM , a...
BioCentriq, Inc.—a New Jersey-based, cell and gene therapy contract development and manufacturing organization (CDMO)—announced today that they've completed a study designed to test transfection of T-cells with GFP mRNA for evaluation of cell viability, transfection efficiency, and post...
Authors: Dr. Mikey Creane (ISCT- Early Stage Professionals Committee) Regenerative Medicine Institute University of Galway Ireland Dr. Rachel Burga (ISCT-Early stage Professionals Committee-Co Chair) Obsidian Therapeutics Cambridge Massachusetts USA On the 24 th of...